The Parker Institute for Cancer Immunotherapy and Xyphos Biosciences announced a collaboration to create universal CAR-T therapies to treat multiple cancer types using the company’s “convertibleCAR” platform.
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
